Clinical Trial

The Efficacy and Safety of Temozolomide in SDH-deficient GIST

Name: The Efficacy and Safety of Temozolomide in SDH-deficient GIST — clinical trial record (NCT05661643)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GIST

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to investigate the efficacy and safety of temozolomide in SDH deficiency GIST patients.

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2022-12-14; most recent amendment 2026-04-02.

Status change: Not Yet Recruiting → Recruiting 2024-02-26

Trial Details

NCT Number	NCT05661643
Lead Sponsor	Asan Medical Center
Conditions	Gastrointestinal Stromal Tumors
Enrollment	29 participants
Start Date	2023-06-28
Primary Completion	2026-12-01 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-07